Center For Technology Commercialization

Four renal biomarkers: transferrin (TF), ceruloplasmin (Cp), lipocalin-type prostaglandin-D synthetase (L-PGDS), and alpha-1-acid glycoprotein (AGP), are capable of accurately diagnosing and determining the course of LN in both children and adults with systemic lupus erythematosis (SLE). While each individual biomarker can be used alone, the combination of two or more of these biomarkers improves diagnostic capability.

Patent Information:

Category(s):

For Information, Contact:

Jere Brophy, Sr. Technology Manager

Cincinnati Children's Hospital Medical Center

3333 Burnet Ave. MLC 7032
Cincinnati, OH 45229
513-803-7944

Jon.Brophy@cchmc.org
3333 Burnet Ave. ML7032, Cincinnati, OH 45229 | Phone 513-636-4285 | E-mail ctc@cchmc.org